Skip to main content
TipRanks
Go Ultimate75% OFF

Knowles (KN) Q3 2026 Earnings Report

230 Followers

KN Q3 2026 EPS Results

Actual EPS
$0.38
Consensus EPS
$0.36
Beat/Miss
Beat by +$0.02
One Year Ago EPS
$0.33

KN Q3 2026 Revenue Results

Actual Revenue
$184.00M
Expected Revenue
$172.10M
Beat/Miss
Beat by +$11.90M
YoY Revenue Growth
+20.34%

Earnings Announcement Details

Quarter
Q3 2026
Date
10/22/2026
Time
After Close
Conference Call
Thursday, October 22, 2026
KN Upcoming Earnings

Knowles's next earnings date is estimated for February 10, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

KN Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Oct 22, 2026|% Change Since:-0.21%|
Earnings Call Sentiment|Positive

The call was strongly positive, supported by revenue growth above guidance, broad-based Precision Devices demand, robust orders and backlog, improving margins, strong cash generation, debt reduction, favorable 2026 guidance and multiple 2027 growth initiatives. The principal challenges were near-term capacity constraints, a 2% to 3% 2027 stamping headwind, higher planned capital spending, elevated operating expenses and uncertainty around part of industrial demand, but management characterized the broader outlook and execution as strong.

Company Guidance

For the fourth quarter of 2026, revenues are expected to be between $180 million and $190 million, up 14% year-over-year at the midpoint, with R&D expenses between $10 million and $12 million, selling and administrative expenses within the range of $29 million to $31 million, adjusted EBIT margin within the range of 23% to 25%, interest expense of $1.5 million, an effective tax rate of 15% to 19%, EPS within the range of $0.39 to $0.43 per share, up $0.05 or 14% year-over-year at the midpoint, weighted average shares outstanding of 87 million, cash from operating activities within the range of $60 million to $70 million, and capital spending of $8 million; full year capital spending is expected to be approximately 5% of revenues, 2026 revenue growth is expected to be 16% at the midpoint of the guidance range and adjusted EBITDA growth 24% over 2025 levels, and capital spending is expected to be above the historic range of 3% to 5%, increasing to 5% to 7% of revenues in 2027. For 2027, hearing health is expected to perform at historical levels, MSA should still probably be in that 2% to 4% for the full year, with a headwind of about 2% to 3% next year, especially more in the first half, PD is expected to have very strong year-over-year growth in the first half but be relatively flat sequentially because of capacity constraints, and MSA gross margins may be a little 1% or so higher in '27 over '26; Micro Solutions revenue is expected to be closer to $3 million this year, with a clear path north of $5 million next year and north of $10 million in '28 and maybe even more, while the company sees a path within 2 to 3 years from just a little north of 25% EBITDA margins this year to 30%.

  • Strong Third-Quarter Financial PerformanceThird-quarter revenue was $184 million, up 20% year-over-year and above the high end of guidance. EPS was $0.38, up $0.05 or 15% year-over-year and at the high end of guidance, while cash provided by operating activities was $45 million, also at the high end of guidance.
  • Precision Devices Delivered Broad-Based GrowthPrecision Devices revenue was $117 million, up 33% year-over-year, with strong demand across MedTech, defense, industrial and electrification. Growth was supported by both OEM customers and distribution channel partners.
  • Strong Orders and Backlog in Precision DevicesPrecision Devices had a third-quarter book-to-bill ratio of 1.5, with nearly $180 million of orders, well above second-quarter orders. Order strength was broad-based across key end markets, OEMs and distribution partners, and the company cited a healthy backlog and continued design wins.
  • MedTech and Specialty Audio GrowthMedTech & Specialty Audio revenue was $67 million, up 4% year-over-year. Hearing health customers' AI-enabled product launches drove demand slightly earlier than usual, while the company continued to expect the hearing health market to grow at historical rates in 2026.
  • Demand Across Medical and Defense ApplicationsPulse power film capacitors continued to win in defibrillator and radiotherapy applications, while ceramic capacitors secured design wins in next-generation medical imaging and implantables. Defense demand remained strong across RF filters, film capacitors and ceramic capacitors for munitions and communications applications.
  • Electrification and Industrial Design-Win MomentumThe company reported continued opportunities in electrification and industrial markets, including ceramic capacitors and capacitor assemblies used in plasma generators for semiconductor equipment. Management also cited strong design activity for faster, more precise and higher-output applications.
  • Capacity Expansion UnderwayKnowles is adding capacity across most Precision Devices product lines to support strong orders, backlog and design wins. Additional capacity is expected to begin coming online in late Q1 and be fully available in the second half of 2027.
  • Capital Returns and Debt ReductionDuring the third quarter, the company repurchased 695,000 shares for $25 million and reduced outstanding bank borrowings by $15 million while also funding organic growth initiatives.
  • Strong Liquidity and Balance SheetKnowles exited the quarter with $47 million of cash and $116 million of borrowings under its revolving credit facility. Net leverage was 0.4x based on trailing-twelve-month adjusted EBITDA, and liquidity exceeded $330 million, including cash and unused revolving-credit capacity.
  • Lower Interest ExpenseThird-quarter interest expense was $1.6 million, down $700,000 from the third quarter of 2025 due to lower average debt balances.
  • Positive Fourth-Quarter GuidanceFourth-quarter revenue is expected to be $180 million to $190 million, representing 14% year-over-year growth at the midpoint. Adjusted EBIT margin is projected at 23% to 25%, EPS at $0.39 to $0.43 per share, up $0.05 or 14% year-over-year at the midpoint, and cash from operating activities at $60 million to $70 million.
  • Raised 2026 Growth Outlook Versus Prior TargetsBased on strong results through the first three quarters, robust backlog and increased order activity, management expects 2026 revenue growth of 16% at the midpoint and adjusted EBITDA growth of 24% over 2025 levels. Both metrics are expected to be well above the high end of the target ranges provided at the May 2025 Investor Day.
  • Long-Term Margin Expansion OpportunityManagement expects to exit 2026 above 25% EBITDA margin and sees a path to 30% EBITDA margins within 2 to 3 years. The stated drivers are approximately 100 basis points of annual gross-margin improvement and 50 to 100 basis points of operating leverage from growth.
  • 2027 Organic Growth and SAM ExpansionManagement expects 2027 organic growth to continue exceeding the revenue targets presented at the May 2025 Investor Day as Precision Devices capacity is added, new design wins ramp, backlog is fulfilled and MedTech & Specialty Audio continues at historical growth levels. The company also expects meaningful expansion of its served available market through new products, existing technologies applied to new customers and markets, and increased content with current customers.
  • Micro Solutions Growth TrajectoryMicro Solutions revenue was approximately $1 million in 2025 and is expected to reach $2 million to $3 million, probably closer to $3 million, in 2026. Management sees a clear path to more than $5 million in 2027 and more than $10 million in 2028.
  • Energy Order Fully RampedThe energy order, identified as a $75 million order, is fully ramped, with output, margins and delivery performance tracking expectations. The company has approximately 6 to 7 more quarters of deliveries remaining.
  • New Growth Platforms ProgressingManagement cited opportunities in pulse power capacitors, attenuators and inductors. Pulse power has additional potential applications, including downhole applications, while initial customer reactions to attenuators and inductors were described as encouraging.
  • Cornell Business Margin ImprovementThe former Cornell specialty film business, acquired by Knowles, is exiting the year with gross margins in the mid-30% range versus 27% to 28% at acquisition, with a stated path above 40%. Automation, improved yields and lower overhead are expected to support further improvement.
  • Pricing and Productivity Support Against InflationManagement said the pricing environment is positive and that the company generally implements moderate annual price increases. Ongoing productivity, yield improvement, capacity utilization and factory-floor initiatives were identified as levers that can benefit 2027 gross margins.

KN Earnings History

KN earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 10, 20272026 (Q4)0.41-0.36――
Oct 22, 20262026 (Q3)0.360.380.3315.15% (+0.05)
Jul 23, 20262026 (Q2)0.300.330.2437.50% (+0.09)
Apr 23, 20262026 (Q1)0.240.270.1850.00% (+0.09)
Feb 05, 20262025 (Q4)0.350.360.2733.33% (+0.09)
Oct 23, 20252025 (Q3)0.310.330.2626.92% (+0.07)
Jul 24, 20252025 (Q2)0.230.240.240.00% (+0.00)
Apr 24, 20252025 (Q1)0.180.180.2-10.00% (-0.02)
Feb 13, 20252024 (Q4)0.280.270.28-3.57% (-0.01)
Oct 24, 20242024 (Q3)0.280.260.31-16.13% (-0.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed